Literature DB >> 27400990

Rift Valley fever virus: Unanswered questions.

Brian H Bird1, Anita K McElroy2.   

Abstract

This mosquito-borne pathogen of humans and animals respects no international or geographic boundaries. It is currently found in parts of Africa and the Arabian Peninsula where periodic outbreaks of severe and fatal disease occur, and threatens to spread into other geographic regions. In recent years, modern molecular techniques have led to many breakthroughs deepening our understanding of the mechanisms of RVFV virulence, phylogenetics, and the creation of several next-generation vaccine candidates. Despite tremendous progress in these areas, other challenges remain in RVF disease pathogenesis, the virus life-cycle, and outbreak response preparedness that deserve our attention. Here we discuss and highlight ten key knowledge gaps and challenges in RVFV research. Answers to these key questions may lead to the development of new effective therapeutics and enhanced control strategies for this serious human and veterinary health threat. Published by Elsevier B.V.

Entities:  

Keywords:  Arbovirus; Epizootic; Mosquito; Reservoir; Rift Valley fever virus; Zoonoses

Mesh:

Year:  2016        PMID: 27400990     DOI: 10.1016/j.antiviral.2016.07.005

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  15 in total

1.  Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen.

Authors:  Bonto Faburay; William C Wilson; Arss Secka; Barbara Drolet; D Scott McVey; Juergen A Richt
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

2.  An unusually long Rift valley fever inter-epizootic period in Zambia: Evidence for enzootic virus circulation and risk for disease outbreak.

Authors:  Herman M Chambaro; Kazuyo Hirose; Michihito Sasaki; Brigadier Libanda; Yona Sinkala; Paul Fandamu; Walter Muleya; Fredrick Banda; Joseph Chizimu; David Squarre; Misheck Shawa; Yongjin Qiu; Hayato Harima; Yuki Eshita; Edgar Simulundu; Hirofumi Sawa; Yasuko Orba
Journal:  PLoS Negl Trop Dis       Date:  2022-06-02

Review 3.  Global research trends of World Health Organization's top eight emerging pathogens.

Authors:  Waleed M Sweileh
Journal:  Global Health       Date:  2017-02-08       Impact factor: 4.185

4.  Wetlands, wild Bovidae species richness and sheep density delineate risk of Rift Valley fever outbreaks in the African continent and Arabian Peninsula.

Authors:  Michael G Walsh; Allard Willem de Smalen; Siobhan M Mor
Journal:  PLoS Negl Trop Dis       Date:  2017-07-25

5.  Broad-Range Antiviral Activity of Hydrogen Sulfide Against Highly Pathogenic RNA Viruses.

Authors:  Nikolay Bazhanov; Olivier Escaffre; Alexander N Freiberg; Roberto P Garofalo; Antonella Casola
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

Review 6.  A Review of Bunyamwera, Batai, and Ngari Viruses: Understudied Orthobunyaviruses With Potential One Health Implications.

Authors:  M Fausta Dutuze; Manassé Nzayirambaho; Christopher N Mores; Rebecca C Christofferson
Journal:  Front Vet Sci       Date:  2018-04-12

7.  Identification of Bunyamwera and Possible Other Orthobunyavirus Infections and Disease in Cattle during a Rift Valley Fever Outbreak in Rwanda in 2018.

Authors:  Marie Fausta Dutuze; Angelique Ingabire; Isidore Gafarasi; Solange Uwituze; Manassé Nzayirambaho; Rebecca C Christofferson
Journal:  Am J Trop Med Hyg       Date:  2020-04-16       Impact factor: 2.345

Review 8.  The challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposal.

Authors:  Emilie Javelle; Alexandre Lesueur; Vincent Pommier de Santi; Franck de Laval; Thibault Lefebvre; Guillaume Holweck; Guillaume André Durand; Isabelle Leparc-Goffart; Gaëtan Texier; Fabrice Simon
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-01-22       Impact factor: 3.944

9.  Absence of Evidence of Rift Valley Fever Infection in Eulemur fulvus (Brown Lemur) in Mayotte During an Interepidemic Period.

Authors:  Raphaëlle Métras; Laure Dommergues; Katia Ortiz; Marion Pannequin; Christian Schuler; Patrick Roux; John W Edmunds; Matt J Keeling; Catherine Cêtre-Sossah; Eric Cardinale
Journal:  Vector Borne Zoonotic Dis       Date:  2017-02-21       Impact factor: 2.133

10.  Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.

Authors:  Utpal Kumar Adhikari; M Mizanur Rahman
Journal:  Infect Genet Evol       Date:  2017-11-01       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.